Tag: Axial spondyloarthritis prevalence
FDA Approval of Bimekizumab for Psoriatic Arthritis and Axial Spondyloarthritis
Bimekizumab-bkzx, also known as Bimzelx, has recently received FDA approval for the treatment of four chronic immune-mediated inflammatory diseases. These include psoriatic arthritis, nonradiographic...